Contemporary management of refractory hypertension

被引:12
作者
Alper Jr. A.B. [1 ]
Calhoun D.A. [1 ]
机构
[1] Address Vascular Biology and Hypertension Program, University of Alabama, Birmingham, AL 35242
关键词
Obstructive Sleep Apnea; Sleep Apnea; Resistant Hypertension; Home Blood Pressure; Contemporary Management;
D O I
10.1007/s11906-999-0055-0
中图分类号
学科分类号
摘要
Refractory or resistant hypertension is conventionally defined as systolic or diastolic blood pressure that remains uncontrolled despite sustained therapy with at least three different classes of antihypertensive agents. Refractory hypertension is estimated to affect less than 5% of the general population with hypertension; however, its prevalence increases with increasing severity of blood pressure. Patients presenting with refractory hypertension usually have progressed from mild, to moderate, to severe hypertension because of lack of or inadequate treatment. Other common contributing factors include obesity, medical nonadherence, suboptimal medical regimens, excessive dietary salt ingestion, secondary forms of hypertension, sleep apnea, and ingestion of substances that interfere with treatment. Combination therapy that includes appropriate doses of a diuretic is recommended for treatment of refractory hypertension. Use of fixed-dose combinations enhances compliance through cost savings, more convenient dosing, and reduced pill burdens. Copyright © 1999 by Current Science, Inc.
引用
收藏
页码:402 / 407
页数:5
相关论文
共 22 条
[1]  
Materson B.J., Reda D.J., Cushman W.C., Henderson W.G., Results of combination anti-hypertensive therapy after failure of each of the components, J Human Hypertens, 9, pp. 791-796, (1995)
[2]  
Hansson L., Zanchetti A., Carruthers S.G., Et al., Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial, Lancet, 351, pp. 155-1762, (1998)
[3]  
Moser M., Current recommendations for initial therapy in hypertension: Are they still valid?, Am J Hypertens, 11, (1998)
[4]  
Schwartz G.L., Sheps S.G., A review of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Curr Opin Cardiol, 14, pp. 161-168, (1999)
[5]  
Yakovlevitch M., Black H.R., Resistant hypertension in a tertiary care clinic, Arch Intern Med, 151, pp. 1786-1792, (1991)
[6]  
Johnson A.G., Nguyen T.V., Day R.O., Do nonsteroidal antiinflammatory drugs affect blood pressure?, Ann Intern Med, 121, pp. 289-300, (1994)
[7]  
Jee S.H., He J., Whelton P.K., Et al., The effect of chronic coffee drinking on blood pressure: A meta-analysis of controlled clinical trials, Hypertension, 33, pp. 647-652, (1999)
[8]  
Omvik P., How smoking affects blood pressure, Blood Press, 5, pp. 71-77, (1996)
[9]  
Cushman W.C., Alcohol and blood pressure, Hypertension Primer Second Edition: The Essentials of High Blood Pressure, pp. 263-265, (1999)
[10]  
Palatini P., Dorigatti F., Roman E., Et al., White-coat hypertension: A selection bias?, J Hypertens, 16, pp. 977-984, (1998)